Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Istradefylline in Recreational Drug Users
NCT02609477Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Istradefylline in Parkinson's disease (PD) (6 arms), sponsored by Kyowa Kirin. Primary endpoint: Drug Liking Visual Analog Scale at 24 hours. Started Jan 2016; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02609477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609477.